Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer

Bibliographic Details
Main Authors: Rui Xu, Hui Peng, Ning Yang, Zhenping Liu, Wei Lu
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-01-01
Series:Genes and Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304222000125
_version_ 1797702695862140928
author Rui Xu
Hui Peng
Ning Yang
Zhenping Liu
Wei Lu
author_facet Rui Xu
Hui Peng
Ning Yang
Zhenping Liu
Wei Lu
author_sort Rui Xu
collection DOAJ
first_indexed 2024-03-12T04:54:38Z
format Article
id doaj.art-48bfeae392ca41cc855bec5d5baeabfc
institution Directory Open Access Journal
issn 2352-3042
language English
last_indexed 2024-03-12T04:54:38Z
publishDate 2023-01-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj.art-48bfeae392ca41cc855bec5d5baeabfc2023-09-03T09:15:48ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422023-01-011011013Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancerRui Xu0Hui Peng1Ning Yang2Zhenping Liu3Wei Lu4Key Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China; Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, ChinaDepartment of Obstetrics and Gynecology, The Fifth People's Hospital of Jinan, Jinan, Shandong 250022, ChinaKey Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, ChinaKey Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, ChinaKey Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Corresponding author. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.http://www.sciencedirect.com/science/article/pii/S2352304222000125
spellingShingle Rui Xu
Hui Peng
Ning Yang
Zhenping Liu
Wei Lu
Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
Genes and Diseases
title Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
title_full Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
title_fullStr Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
title_full_unstemmed Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
title_short Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
title_sort nuclear lncrna cerna1 enhances the cisplatin induced cell apoptosis and overcomes chemoresistance via epigenetic activation of bcl2l10 in ovarian cancer
url http://www.sciencedirect.com/science/article/pii/S2352304222000125
work_keys_str_mv AT ruixu nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer
AT huipeng nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer
AT ningyang nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer
AT zhenpingliu nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer
AT weilu nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer